HEALTH

DOYLESTOWN, Pa. — ProPhase Labs on Thursday announced its title sponsor of the "Cold-Eeze Skate for the Heart" show, airing on NBC stations Jan. 16 from 4 to 6 p.m., EST.

"We are so proud to support these world-class skaters and the critical heart health cause," stated Ted Karkus, CEO of ProPhase Labs. "We are also huge fans of the amazing singers in the show."

MAGNOLIA, Texas — Pernix Therapeutics Holdings on Wednesday announced an exclusive co-promotion agreement with ParaPro for a medication to treat head lice.

A new drug application for the prescription product currently is under review by the Food and Drug Administration. The proposed medication contains the active ingredient spinosad, which is derived from a naturally occurring soil bacterium.

CHICAGO — With the explosion in such mobile devices as smart phones, Walgreens is expanding its access across an ever-wider array of options for health consumers, president and CEO Greg Wasson told shareholders at the company’s annual meeting Wednesday.

ALEXANDRIA, Va. — The American Diabetes Association is honoring Sen. Susan Collins, R-Maine, for demonstrating leadership and commitment in stopping diabetes.

LAS VEGAS — Nevada Sen. Sheila Leslie, D-Reno, is working with Carson City district attorney Neil Rombardo on introducing a bill to require a prescription for pseudoephedrine as a tool to cut down on illicit methamphetamine production, the Las Vegas Review-Journal reported Wednesday evening.

PRINCETON, N.J. — Danish drug maker Novo Nordisk has created an online resource for diabetes patients that educates them about Novo Nordisk drugs and devices, recipes and nutritional values, and allows them to connect with other patients.

MINNEAPOLIS — Supervalu on Thursday announced the expansion of its exclusive in-store nutritional navigation program, "Nutrition iQ," to include the fresh food departments and more robust nutrition information for the center store.

ORLANDO, Fla. — Companies that lower co-payments on prescription drugs while promoting disease management can lower their own healthcare costs, according to a three-year study commissioned by the Florida Health Care Coalition and published in the journal Health Affairs.

The study, which focused on patients with diabetes, found that companies combining disease-management programs with “value-based insurance design” can earn a return of $1.33 for every dollar they spend upfront on medication.